Global Nucleic Acid Amplification Testing Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Nucleic Acid Amplification Testing Market was valued at $10.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 9.5% CAGR, to an estimated market size of $16.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The Nucleic Acid Amplification Testing (NAAT) market comprises molecular diagnostic technologies and assays designed to detect and amplify specific DNA or RNA sequences to identify pathogens or genetic markers. The scope includes PCR-based platforms, isothermal amplification (INAAT), and next-generation sequencing (NGS) used across infectious disease diagnostics, oncology, genetic testing, and blood screening, while excluding traditional culture-based methods and simple rapid antigen tests.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Nucleic Acid Amplification Testing Market in the period 2025-30:
- The rapid adoption of Point-of-Care (POC) and decentralized testing platforms is shifting diagnostics from centralized labs to clinics and rural settings.
- Increasing integration of Isothermal Amplification (INAAT) technologies like LAMP and RPA offers faster, cost-effective alternatives to traditional thermal cycling.
- The expansion of Oncology applications, particularly liquid biopsy and ctDNA companion diagnostics, is positioning molecular testing as a high-growth frontier.
- Rising demand for Multiplexed Respiratory Panels allows for the simultaneous detection of multiple pathogens, improving clinical decision-making and hospital efficiency.
- Advancements in Automation and 'sample-to-answer' closed systems are reducing human error, contamination risks, and the need for highly specialized personnel.
- The implementation of Artificial Intelligence (AI) for automated result interpretation and sample triage is addressing global shortages in laboratory staffing.
- Post-pandemic Infrastructure Investments and government funding are catalyzing laboratory capacity and diagnostic readiness in emerging economies.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Infectious Disease Testing
- Oncology & Precision Medicine
- Genetic Testing & Others